On November 20, 2023, ReShape Lifesciences Inc. (NASDAQ: RSLS) opened at $0.2451, lower -4.12% from the last session. During the day, the shares moved up to $0.25 and dropped to $0.2284 before settling in for the closing price of $0.24. Price fluctuations for RSLS have ranged from $0.19 to $22.40 over the past 52 weeks.
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 35.05%. With a float of $12.94 million, this company’s outstanding shares have now reached $13.14 million.
The extent of productivity of a business whose workforce counts for 40 workers is very important to gauge. In terms of profitability, gross margin is +60.52, operating margin of -240.91, and the pretax margin is -414.54.
ReShape Lifesciences Inc. (RSLS) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Medical Devices industry is another important factor to consider. The insider ownership of ReShape Lifesciences Inc. is 1.47%, while institutional ownership is 3.13%. The most recent insider transaction that took place on Oct 25, was worth 35. In this transaction Chief Financial Officer of this company sold 131 shares at a rate of $0.27, taking the stock ownership to the 22,949 shares. Before that another transaction happened on Oct 11, when Company’s Chief Financial Officer sold 39 for $0.93, making the entire transaction worth $36. This insider now owns 23,080 shares in total.
ReShape Lifesciences Inc. (RSLS) Latest Financial update
If we go through the results of last quarter, which was made public on 9/29/2023, the company posted -$0.8 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -$1.2) by $0.4. This company achieved a net margin of -411.16 while generating a return on equity of -185.85. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.79 per share during the current fiscal year.
ReShape Lifesciences Inc. (NASDAQ: RSLS) Trading Performance Indicators
Check out the current performance indicators for ReShape Lifesciences Inc. (RSLS). In the past quarter, the stock posted a quick ratio of 0.94. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.31.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -39.12, a number that is poised to hit -1.62 in the next quarter
Technical Analysis of ReShape Lifesciences Inc. (RSLS)
The latest stats from [ReShape Lifesciences Inc., RSLS] show that its last 5-days average volume of 0.5 million was inferior to 1.28 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 39.76%. Additionally, its Average True Range was 0.04.
During the past 100 days, ReShape Lifesciences Inc.’s (RSLS) raw stochastic average was set at 3.02%, which indicates a significant decrease from 20.04% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 72.07% in the past 14 days, which was lower than the 107.47% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.3651, while its 200-day Moving Average is $1.9181. Now, the first resistance to watch is $0.2439. This is followed by the second major resistance level at $0.2578. The third major resistance level sits at $0.2655. If the price goes on to break the first support level at $0.2223, it is likely to go to the next support level at $0.2146. The third support level lies at $0.2007 if the price breaches the second support level.
ReShape Lifesciences Inc. (NASDAQ: RSLS) Key Stats
There are currently 13,135K shares outstanding in the company with a market cap of 3.02 million. Presently, the company’s annual sales total 11,240 K according to its annual income of -46,210 K. Last quarter, the company’s sales amounted to 2,160 K and its income totaled -3,530 K.